
The FDA has approved belzutifan for the treatment of advanced renal cell carcinoma- a first-in-class drug discovered and developed by UTSW researchers over three decades. bit.ly/BelzutifanApproval202… @UTSWNews @utswcancer @UTSWInternalMed

The Kidney Cancer Program, part of the Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, is a national leader in research and treatment.

The FDA has approved belzutifan for the treatment of advanced renal cell carcinoma- a first-in-class drug discovered and developed by UTSW researchers over three decades. bit.ly/BelzutifanApproval202… @UTSWNews @utswcancer @UTSWInternalMed

Was asked to contribute to our @UTSWMedCenter inaugural #physicianscientist newsletter about launching a career as a clinician-scientist

In metastatic renal cell carcinoma, pancreatic spread is associated with improved survival. doi.org/10.1172/jci.insight.… Here, James Brugarolas @JBrugarolas & team @KCPUTSW @UTSWMedCenter determine that pancreatic #metastases arise predominantly from indolent clones within primary #RCC and exhibit distinct molecular and histological features, clinical behavior, and treatment responsiveness. The figure shows pancreatic metastasis sample with high angiogenesis, indicated by deep learning vascular mask (red).

Congratulations to Haitao Xu @PayalKapur5 @KCPUTSW and all consortium investigators @montypal @neerajaiims on insight.jci.org/articles/vie…

@HHammersMD discussing @KCPUTSW spinoff #belzutifan @ASCO #GU26

💥Great news for #KidneyCancer research! FY26 includes $15M for KCRP, restoring funding after last year’s cuts. Progress made possible by patients, caregivers, researchers, clinicians, and advocates nationwide. Special thanks to @kidneycan kidneycan.org/kcrp-update/ #KidneyCancer

Proud to see this review published in @JournalCancer. This article traces the scientific journey to #belzutifan and represents the first publication from UT Southwestern authored by investigators involved in its development. #KidneyCancer #CancerResearch
Fun working on this review @JournalCancer about #belzutifan with @TambarLab who were involved in its development and @QianJanieQin @KCPUTSW @UTSWMedCenter pubmed.ncbi.nlm.nih.gov/4163… acsjournals.onlinelibrary.wi…

📣Early registration for the @AACR Innovations in Kidney Cancer Research Conference ends today (Jan 30)! Connect with colleagues, share ideas, and dive into the latest advances in kidney cancer research. 👉 Program & registration: aacr.org/meeting/aacr-specia…

🎉Congrats to Dr. Arijit Mal, a Brugarolas Lab Postdoctoral Researcher, for earning 2nd place in the Translational–Clinical category at the recent @utswcancer Research Retreat, selected from 90+ qualified poster submissions! Well done, Dr. Mal!

🙌 Thank you to @JBrugarolas @KCPUTSW for being the catalyst for this first-ever pre-clinical models workshop! Through collaboration and innovative spirits we continue working to bring better therapies and diagnostics to the #kidneycancer community! #UnstoppableTogether #RCCAMW

Congratulations to @KCPUTSW @UTSWHemeOnc investigators on their @CD_AACR paper bit.ly/MalCanDiscovHCM establishing a role for #HIF2 in PTHrP regulation and hypercalcemia in #renalcancer & @kaelin_lab in press @NatureMedicine.

New Cancer Discovery (@CD_AACR) paper from the Brugarolas Lab! Drs. Arijit Mal & Bingqing Xie, with Dr. @JBrugarolas, reveal a strategy to overcome calcium imbalance in kidney cancer. 🔗bit.ly/MalCanDiscovHCM 🔗utsouthwestern.edu/newsroom/…

UTSW has now taken a new step with AI, developing a system that extracts crucial info from medical records with 99% accuracy. Significantly speeding up data collection and marking a major way forward for more research. #kidneycancer #UTSW utsouthwestern.edu/newsroom/…

Learn more: utsouthwestern.edu/newsroom/…
Scientists at UTSW have discovered that tumors have sugar-coated pathways to grab vitamin E from lipoproteins, allowing for an antioxidant shield that helps cancer survive. Blocking this could help make tumors more vulnerable to treatment. #KidneyCancer #utsw

Scientists at UTSW have discovered that tumors have sugar-coated pathways to grab vitamin E from lipoproteins, allowing for an antioxidant shield that helps cancer survive. Blocking this could help make tumors more vulnerable to treatment. #KidneyCancer #utsw
